J.Jpn. Surg. Soc.
ISSN 1880-1129

[Abstract] [Full Text HTML] [Full Text PDF] （in Japanese / 399KB） [Members Only]

J.Jpn. Surg. Soc.. 118(2): 155-160, 2017

Feature topic

PERIOPERATIVE ORAL MANAGEMENT FOR ESOPHAGEAL CANCER AND LUNG CANCER SURGERY

1) Department of Thoracic, Endocrine Surgery, and Oncology, University of Tokushima Graduate School
2) Department of Oral Care Center, Tokushima University Hospital, Tokushima, Japan

Takeshi Nishino1), Takahiro Yoshida1), Seiya Inoue1), Mariko Aoyama1), Hiromitsu Takizawa1), Akira Tangoku1), Yoshiko Yamamura2), Masayuki Azuma2)

The effectiveness of perioperative oral management in decreasing the risk of postoperative pneumonia has been reported recently. We introduced perioperative oral management for esophageal cancer and lung cancer patients in 2014 and report here its current status and effectiveness for those patients in our institute. Every 100 cases of esophageal cancer and lung cancer patients treated surgically were classified into two groups, i.e., with or without perioperative oral management, and postoperative complications were compared retrospectively. In the lung cancer group, oral management prevented postoperative pneumonia significantly and shortened the length of hospital stays after surgery in comparison with the group without oral management. In the esophageal cancer group, there was little occurrence of postoperative pneumonia in either group. Numerous esophageal cancer patients who received neoadjuvant chemotherapy developed oral mucositis and received oral care treatment before surgery. Such treatment for oral mucositis likely improved the oral environment and prevented postoperative pneumonia. Other patients have also been introduced to the importance of oral care before chemotherapy. Perioperative oral management can prevent postoperative pneumonia in esophageal cancer and lung cancer patients.

<< To previous pageTo next page >>

To read the PDF file you will need Adobe Reader installed on your computer.